Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|December 19, 2007
Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional studyJohane P Allard, Elaheh Aghdassi, Saira Mohammed, et al.
Reviews on Recent Clinical Trials|August 5, 2015
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialAnthony B Miller, Ronald Feld, Robert Fontana, et al.
Journal of Hepatology|November 8, 2016
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in CanadaNaveed Z Janjua, Mei Chong, Margot Kuo, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
The role of hepatic resection in the treatment of hepatocellular cancerSasan Roayaie, Ghalib Jibara, Parissa Tabrizian, et al.
Journal of Hepatology|January 17, 2012
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalysesJean-Luc Raoul, Jordi Bruix, Tim F Greten, et al.
Gastroenterology|January 20, 2026
Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled TrialGrishma Hirode, Hooman F Zangneh, Orlando Cerocchi, et al.
The Journal of Surgical Research|July 14, 2009
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi processElijah Dixon, Christopher Armstrong, Guy Maddern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaAlexis Bujold, Christine A Massey, John J Kim, et al.
Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Journal of Hepatology|August 29, 2017
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosisSuraj A Sharma, Matthew Kowgier, Bettina E Hansen, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|December 19, 2007
Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional studyJohane P Allard, Elaheh Aghdassi, Saira Mohammed, et al.
Reviews on Recent Clinical Trials|August 5, 2015
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialAnthony B Miller, Ronald Feld, Robert Fontana, et al.
Journal of Hepatology|November 8, 2016
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in CanadaNaveed Z Janjua, Mei Chong, Margot Kuo, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
The role of hepatic resection in the treatment of hepatocellular cancerSasan Roayaie, Ghalib Jibara, Parissa Tabrizian, et al.
Journal of Hepatology|January 17, 2012
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalysesJean-Luc Raoul, Jordi Bruix, Tim F Greten, et al.
Gastroenterology|January 20, 2026
Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled TrialGrishma Hirode, Hooman F Zangneh, Orlando Cerocchi, et al.
The Journal of Surgical Research|July 14, 2009
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi processElijah Dixon, Christopher Armstrong, Guy Maddern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaAlexis Bujold, Christine A Massey, John J Kim, et al.
Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Journal of Hepatology|August 29, 2017
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosisSuraj A Sharma, Matthew Kowgier, Bettina E Hansen, et al.
Pageof 16